no it’s not similar as the phase 2 had a single primary end point for inflammatory lesions. Now non inflammatory will be included as an endpoint which was the biggest home run of the lot in phase 2.
while inflammatory may be a 50/50 in phase 3, non inflammatory may just be the added element to take us through to market.
so happy with that after the outcomes of the past 6 months
- Forums
- ASX - By Stock
- Ann: BTX 1503 End of Phase 2 Milestone with FDA
no it’s not similar as the phase 2 had a single primary end...
-
- There are more pages in this discussion • 171 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
38.0¢ |
Change
0.025(7.04%) |
Mkt cap ! $687.8M |
Open | High | Low | Value | Volume |
36.5¢ | 38.0¢ | 36.0¢ | $3.158M | 8.589M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 141840 | 37.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 135173 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 121840 | 0.375 |
4 | 61036 | 0.370 |
6 | 265949 | 0.365 |
14 | 404962 | 0.360 |
14 | 404158 | 0.355 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 135173 | 2 |
0.385 | 76800 | 4 |
0.390 | 567200 | 7 |
0.395 | 451501 | 6 |
0.400 | 910507 | 17 |
Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online